<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS136958</article-id>
<article-id pub-id-type="doi">10.1101/2021.10.13.464225</article-id>
<article-id pub-id-type="archive">PPR407668</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased mTOR signaling, impaired autophagic flux and cell-to-cell viral transmission are hallmarks of SARS-CoV-2 infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Maktura</surname>
<given-names>Grazielle Celeste</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Dias</surname>
<given-names>Thomaz Luscher</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zambalde</surname>
<given-names>Érika Pereira</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Brenha</surname>
<given-names>Bianca</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Amorim</surname>
<given-names>Mariene R.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santos</surname>
<given-names>Luana Nunes</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buscaratti</surname>
<given-names>Lucas</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Angeli Elston</surname>
<given-names>João Gabriel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mara</surname>
<given-names>Cynthia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mancini</surname>
<given-names>Mariana Camargo Silva</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pavan</surname>
<given-names>Isadora Carolina Betim</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Toledo-Teixeira</surname>
<given-names>Daniel A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bispo-dos-Santos</surname>
<given-names>Karina</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parise</surname>
<given-names>Pierina L.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muraro</surname>
<given-names>Stefanie Primon</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Souza</surname>
<given-names>Gabriela Fabiano</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morelli</surname>
<given-names>Ana Paula</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>da Silva</surname>
<given-names>Luiz Guilherme Salvino</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Castro</surname>
<given-names>Ícaro Maia Santos</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barbosa</surname>
<given-names>Guilherme O.</given-names>
</name>
<xref ref-type="aff" rid="A15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ludwig</surname>
<given-names>Raissa G.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knittel</surname>
<given-names>Thiago L.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saccon</surname>
<given-names>Tatiana D.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mori</surname>
<given-names>Marcelo A.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Granja</surname>
<given-names>Fabiana</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carvalho</surname>
<given-names>Hernandes F.</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>da Silva</surname>
<given-names>Luis Lamberti Pinto</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakaya</surname>
<given-names>Helder I.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Proenca-Modena</surname>
<given-names>Jose Luiz</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simabuco</surname>
<given-names>Fernando Moreira</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marques-Souza</surname>
<given-names>Henrique</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Brazilian Laboratory on Silencing Technologies (BLaST), Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas; Campinas, São Paulo, Brazil</aff>
<aff id="A2">
<label>2</label>Multidisciplinary Laboratory of Food and Health (LabMAS), School of Applied Sciences (FCA), University of Campinas (UNICAMP); Limeira, São Paulo, Brazil</aff>
<aff id="A3">
<label>3</label>Laboratory of Signaling Mechanisms (LMS), School of Pharmaceutical Sciences (FCF), University of Campinas (UNICAMP); Campinas, São Paulo, Brazil</aff>
<aff id="A4">
<label>4</label>Laboratory of Emerging Viruses (LEVE), Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas (UNICAMP); Campinas, São Paulo, Brazil</aff>
<aff id="A5">
<label>5</label>Biodiversity Research Centre, Federal University of Roraima, Boa Vista, RR, Brazil</aff>
<aff id="A6">
<label>6</label>Computational Systems Biology Lab (CSBL), Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo; São Paulo, São Paulo, Brazil</aff>
<aff id="A7">
<label>7</label>Center of Research in Inflammatory Diseases (CRID), Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; Ribeirão Preto, São Paulo, Brazil</aff>
<aff id="A8">
<label>8</label>Laboratório de Genética Bioquímica, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Brazil</aff>
<aff id="A9">
<label>9</label>Experimental Medicine Research Cluster (EMRC), University of Campinas (UNICAMP), Campinas, Brazil. Experimental Medicine Research Cluster, University of Campinas, Campinas, SP, Brazil</aff>
<aff id="A10">
<label>10</label>Laboratory of Aging Biology, Department of Biochemistry and Tissue Biology, University of Campinas (UNICAMP), Campinas, Brazil</aff>
<aff id="A11">
<label>11</label>Obesity and Comorbidities Research Center (OCRC), University of Campinas (UNICAMP), Campinas, Brazil</aff>
<aff id="A12">
<label>12</label>Department of Structural and Functional Biology, University of Campinas, Campinas, São Paulo, Brazil</aff>
<aff id="A13">
<label>13</label>Department of Cell Biology Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; Ribeirão Preto, São Paulo, Brazil</aff>
<aff id="A14">
<label>14</label>Center for Virology Research, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil</aff>
<aff id="A15">
<label>15</label>Cardiovascular Research Institute, University of California San Francisco, CA, USA</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Corresponding author <email>simabuco@gmail.com</email>.</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="preprint">
<day>14</day>
<month>10</month>
<year>2021</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">The COVID-19 disease caued by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has two characteristics that distinguish it from other viral infections. It affects more severely people with pre-existing comorbidities and viral load peaks prior to the onset of the symptoms. Investigating factors that could contribute to these characteristics, we found increased mTOR signaling and suppressed genes related to autophagy, lysosome, and vesicle fusion in Vero E6 cells infected with SARS-CoV-2. Transcriptomic data mining of bronchoalveolar epithelial cells from severe COVID-19 patients revealed that COVID-19 severity is associated with increased expression of genes related to mTOR signaling and decreased expression of genes related to autophagy, lysosome function, and vesicle fusion. SARS-CoV-2 infection in Vero E6 cells also resulted in virus retention inside the cells and trafficking of virus-bearing vesicles between neighboring cells. Our findings support a scenario where SARS-CoV-2 benefits from compromised autophagic flux and inhibited exocytosis in individuals with chronic hyperactivation of mTOR signaling, which might relate to undetectable proliferation and evasion of the immune system.</p>
</abstract>
<kwd-group>
<kwd>COVID-19</kwd>
<kwd>coronaviruses</kwd>
<kwd>mTOR</kwd>
<kwd>single-cell analysis</kwd>
<kwd>cell-to-cell transmission</kwd>
<kwd>autophagic flux</kwd>
<kwd>Sars-Cov-2</kwd>
<kwd>Vero E6</kwd>
<kwd>exocytosis</kwd>
<kwd>BALF</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p id="P2">The new coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) became a pandemic, severely affecting people with pre-existing comorbidities, such as hypertension, diabetes, obesity, and heart disease [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref>]. Increased signaling through the mammalian/mechanistic Target of Rapamycin (mTOR) signaling pathway is a common characteristic in all comorbidities associated with a higher risk of mortality by COVID-19 [<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R8">8</xref>]. In healthy individuals, mTOR signaling is responsible for maintaining a balance between protein synthesis, autophagy, and nutrient storage processes. This balance is crucial for the cell since its dysregulation leads to cancer, obesity, and diabetes [<xref ref-type="bibr" rid="R9">9</xref>]. Chronic mTOR hyperactivation is found in several diseases [<xref ref-type="bibr" rid="R10">10</xref>]. The process of autophagy, from autophagosome formation until lysosomal degradation, depends on the inactivation of mTOR signaling [<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R12">12</xref>]. Interestingly, an interactomics study identified mTOR signaling as a pathway possibly modulated by SARS-CoV-2 infection [<xref ref-type="bibr" rid="R13">13</xref>]. Also, recent findings showed that SARS-CoV-2 infected cells have compromised autophagic flux and increased virus replication [<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>]. Therefore, it is tempting to predict that the balance between mTOR and autophagy could link comorbidities to severe COVID-19 symptoms.</p>
<p id="P3">Differently from the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), SARS-CoV-2 viral load peaks before the onset of the symptoms and remains elevated for up to three weeks [<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref>]. It is still unknown the reason why SARS-CoV-2 can proliferate and remain undetectable by the immune system during the early stages of the disease. Interestingly, high mTOR and low lysosomal activation correlate with reduced exocytosis [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R18">18</xref>], suggesting a possible link between mTOR, autophagy, and virus release from infected cells.</p>
<p id="P4">In this report, we analyzed molecular pathways of SARS-CoV-2 infection in Vero E6 cells and COVID-19 patients to evaluate the balance between the mTOR signaling pathway and the process of autophagy and their correlation with viral release and transmission by cell-to-cell connections, a phenomenon usually associated with viral persistence and immune evasion. Our findings reveal that SARS-CoV-2 infection in Vero E6 cells and severe COVID-19 patients occur in conditions of increased mTOR activity and impaired autophagic flux that could prevent the viral release and promote cell-to-cell viral transmission. These data may help to explain why the SARS-CoV-2 load peak occurs before COVID-19 symptoms and the exacerbated activation of the immune response seen in severely affected COVID-19 patients.</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<label>2</label>
<title>Materials and Methods</title>
<sec id="S3">
<title>Vero E6</title>
<p id="P5">Vero E6 (African green monkey, <italic>Cercopithicus aethiops</italic>, kidney) cells were cultured in Dulbecco’s modified Eagle medium (DMEM; Sigma-Aldrich, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Sigma-Aldrich, USA) and 1% Penicillin-Streptomycin 100 U/mL and 100 μg/mL (Sigma-Aldrich, USA), and incubated in 5 % carbon dioxide atmosphere at 37 °C.</p>
</sec>
<sec id="S4">
<title>Viral infection</title>
<p id="P6">An aliquot of SARS-CoV-2 SP02.2020 (GenBank accession number MT126808) isolate was kindly donated by Professor Edison Luiz Durigon of the University of São Paulo, São Paulo [<xref ref-type="bibr" rid="R19">19</xref>]. Vero E6 cells were used for virus propagation in the Biosafety Level 3 Laboratory (BSL-3) of the Laboratory of Emerging Viruses. Viral infections were performed in Vero cells seeded in 24 wells plates (5 × 10<sup>5</sup> cells/well) for the experiments with treatments and immunofluorescence assays, and 6 wells plates (1 × 10<sup>6</sup> cells/well) for Western blots. A multiplicity of infection (MOI) of 1 was used for all experiments.</p>
</sec>
<sec id="S5">
<title>Plaque-forming units’ assay (PFU)</title>
<p id="P7">PFU assay was performed to access viral titer in the supernatant of infected cells and experimental samples as previously described, with modifications [<xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R20">20</xref>]. Briefly, 24 wells plates were seeded with Vero E6 cells at a quantity of 5 × 10<sup>5</sup> cells/well. Six 10-fold dilutions of the samples were performed and transferred as duplicates to the wells. Positive and negative control of SARS-CoV-2 was included. The plates were incubated for 1 h for adsorption in a rocking platform at room temperature. Then, a semisolid medium, containing 1 % carboxymethyl cellulose (CMC) (Sigma-Aldrich, USA) in DMEM, 2 % FBS, and 1 % of penicillin-streptomycin, was added to the wells. The plates were incubated at 37 °C, 5 % of CO<sub>2</sub> atmosphere for 48 h. The semisolid medium was then removed, cells were fixed with paraformaldehyde 8 % for 30 minutes, washed with distilled water, and stained with methylene blue (Sigma-Aldrich, USA).</p>
<p id="P8">To access the production of viable viral particles inside Vero cells in the experiments, the supernatants were removed from the wells, cells were washed once with PBS 1X, and the monolayer was collected and frozen with liquid nitrogen, followed by three series of freeze-and-thaw in liquid nitrogen and 37 °C water bath. These samples were titrated by PFU.</p>
</sec>
<sec id="S6">
<title>Bafilomycin treatment</title>
<p id="P9">For the bafilomycin experiment, cells were cultured in 24-well plates as described above, followed by washing with phosphate-buffered saline (PBS) and treated with 10 nM of bafilomycin in DMEM 10% FBS for 3 hours. Treatment was withdrawn two hours prior to infection and 24 hpi [<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22">22</xref>] cells and supernatant samples were titrated by PFU as previously described.</p>
</sec>
<sec id="S7">
<title>Probe synthesis</title>
<p id="P10">The first step to generate the probe was to amplify the RdRp gene target from SARS-CoV-2 cDNA using GoTaq<sup>®</sup> DNA Polymerase PCR kit (Promega) and the following oligonucleotide primers RdRp Fwd 5’-AACACGCAAATTAATGCCTGTCTG 3’ and RpRd Rev 5’ GTAACAGCATCAGGTGAAGAAACA 3’. The polymerase chain reaction 1 (PCR 1) was carried out in a total volume of 50 μL containing 10 μL 5X GoTaq reaction buffer, 2 μL MgCl2, 1 μL dNTP mix (10 mM), 1 μL of each RdRp primer (10 mM), 1 μL cDNA (1:10 dilution), 0.25 μL GoTaq<sup>®</sup> DNA Polymerase (5 u/μL) and 33.75 μL nuclease-free water. The thermocycler program for each PCR reaction began with an initial denaturation step at 95 °C for 2 min followed by 35 cycles of 30 seconds denaturation step at 95 °C, a 30 seconds annealing step at 55 °C, and a 30 seconds elongation step at 72 °C, then one final 5 min extension step at 72 °C.</p>
<p id="P11">For the incorporation of biotin molecules into the probe, biotin-16-deoxyuridine (bio-16-dUTP) (Sigma-Aldrich, USA) was substituted for the appropriate unlabeled dNTP in the following polymerase reaction mix. The PCR 2 was carried out with almost the same design as PCR 1 but 1 μL from PCR 1 product was used as template DNA, and in place of 1 μL dNTP mix, 1 μL d (A, C, G) TP (10 mM) and 0.5 μL 16dUTP (0.2 mM) were used. In the course of PCR 2, the biotin 16-dUTP is incorporated into the newly synthesized complementary DNA strands. The final result of this procedure is a 300 bp biotinylated DNA probe with the following sequence: 5′-AACACGCAAATTAATGCCTGTCTGTGTGGAAACTAAAGCCATAGTTTCAACTATACAGCGTAAAT ATAAGGGTATTAAAATACAAGAGGGTGTGGTTGATTATGGTGCTAGATTTTACTTTTACACCAGT AAAACAACTGTAGCGTCACTTATCAACACACTTAACGATCTAAATGAAACTCTTGTTACAATGCC ACTTGGCTATGTAACACATGGCTTAAATTTGGAAGAAGCTGCTCGGTATATGAGATCTCTCAAAG TGCCAGCTACAGTTTCTGTTTCTTCACCTGATGCTGTTAC-3′.</p>
</sec>
<sec id="S8">
<title>Fluorescent In situ Hybridization (FISH)</title>
<p id="P12">Infected cells were fixed using PFA 4 % pH 7.4 prepared in PBS 1X pH 7.4 DEPC for 20 minutes at room temperature. After that, cells were washed 3X using PBS DEPC solution to remove remains of the fixation process. Following, cells were treated with a 2% H<sub>2</sub>O<sub>2</sub> solution in methanol for 30 minutes at room temperature and protected from the light, to avoid autofluorescence. Then, cells were washed with PBS DEPC to remove remains of the treatment and incubated for 2 minutes at room temperature in a solution of Proteinase K (10 μg/mL) diluted in PBST 0.1 M pH 7.4 DEPC, to enable cell permeabilization. The reaction was then inactivated using a 2 mg/mL glycine solution, diluted in 0.1M PBST pH 7.4 DEPC for 10 minutes at room temperature. A new fixation was performed using 4% PFA pH 7 for 10 minutes at room temperature. Next, samples were washed with PBS to remove the remains of the fixative.</p>
<p id="P13">To a Pre-Hyb step, the Hyb solution (50 % formamide, 10 % dextran sulfate, and 2x SSC pH 7) was used supplemented with salmon sperm DNA (2 μg/mL) to avoid nonspecific signals, for 2 hours at 37 °C in a humid box. Then, the incubation was performed using Hyb solution with the biotinylated probe from PCR 2 (100 μL/mL), denaturing the solution at 85 °C and adding to the cells, incubating for 16 hours at 37 °C in a humid box. To remove Hyb gradually, cells were washed with a 50 % Hyb + 2x SSC pH 7 solution for 20 minutes at 37 °C followed by the repetition of the process using a 25 % Hyb + 2x SSC pH 7 solution. Samples were then washed twice with a 2× SSC solution for 10 minutes at 37 °C, followed by a wash using PBS 1X DEPC for at least 5 times to remove Hyb and SSC remains and probe excess that was not hybridized. Finally, Streptavidin- (Invitrogen #21842) diluted 1:500 in PBS 1× DEPC was used to incubate the samples at room temperature for 2 hours, protected from the light, followed by a washing step using PBS to remove the Streptavidin excess.</p>
<p id="P14">DAPI (Santa Cruz Biotechnology - #SC-3598) diluted 1:1000 in PBS solution was incubated for 10 minutes at room temperature and protected from the light. Subsequently, cells were washed with PBS and the labels mounted in an aqueous mounting solution for confocal imaging.</p>
</sec>
<sec id="S9">
<title>Immunofluorescence</title>
<p id="P15">Cells were prepared onto silanized glass slides, fixed, and stained as previously described in the FISH process. Briefly, after fixation with 4 % PFA, cells were washed with 0.1 M PBST pH 7.4. After, cells were incubated per 10 min with 0.1 M glycine and treated with BSA solution (Sigma) for 30 min. Cells were then incubated overnight at 4 °C with primary antibodies at 1:100 dilution in PBST and 1 % BSA [SARS-COV-2 Spike S1 antibody (#HC2001 GenScript - #A02038), p62 antibody (#BD 610832), Lamp1 antibody (#BD 555798) and CD63 antibody (#BD 556019), according to the desired double IF. The slides were washed and incubated for 2 h with secondary antibodies (Alexa 488 anti-Human IgG Thermo Fisher - #A11013 and Alexa Fluor 555 Anti-Mouse IgG #A21422), diluted 1:500 in PBST+ 1 % BSA. Cells were then washed and stained with DAPI (Santa Cruz Biotechnology, #SC3598). Subsequently, cells were washed with PBS and the labels mounted in an aqueous mounting solution for confocal imaging.</p>
</sec>
<sec id="S10">
<title>Confocal microscopy</title>
<p id="P16">Microscopic images were acquired with an Airyscan Zeiss LSM880 on an Axio Observer 7 inverted microscope (Carl Zeiss AG, Germany) with a C Plan Apochromat 63x/1.4 Oil DIC objective, 4x optical zoom. Before image analysis, raw.czi files were automatically processed into deconvoluted Airyscan images using Zen Black 2.3 software. DAPI images were acquired as conventional confocal images using a 405 nm laser line for excitation and pinhole set to 1 AU.</p>
</sec>
<sec id="S11">
<title>VeroE6 RNAseq</title>
<p id="P17">Raw RNA sequencing (RNAseq) reads of VeroE6 cells infected with SARS-CoV-2 at a multiplicity of infection (MOI) of 0.3 for 24 h and mock-infected cells were obtained from SRA (GSE153940) [<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>]. Gene level quantification was performed using Salmon [<xref ref-type="bibr" rid="R25">25</xref>] with the <italic>Chlorocebus sabaeus</italic> reference transcriptome obtained from NCBI as the index. Salmon quant mode was run using standard settings and the following flags: --validate mappings and --numBootrstraps 100. The R package tximport [<xref ref-type="bibr" rid="R26">26</xref>] was used to load quant.sf files to R and to create a DESeq2 object for differential expression analysis. DESeq2 [<xref ref-type="bibr" rid="R27">27</xref>] was used to find differentially expressed genes between SARS-CoV-2 and mock-infected cells using standard settings. Geneset enrichment analysis (GSEA) of differentially expressed genes was performed using the fgsea R package [<xref ref-type="bibr" rid="R28">28</xref>] against a custom geneset containing all pathways and terms from Reactome, Gene Ontology (GO) biological process, GO cellular compartment, GO molecular function, Biocarta, KEGG, Hallmark pathways, and Wikipathways. All original GMT files were obtained from the GSEA-MsigDB webservice [<xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref>]. From the enrichment results containing all terms, pathways related to mTOR signaling, autophagy, lysosome, exocytosis, endosome, late endosome, SNAREs, and vesicle-associated proteins were selected for visualization. Only terms with an adjusted p-value &lt; 0.05 were considered for discussion. Leading-edge genes from the significant terms were used to depict results at the gene level. Figures were elaborated using the ggplot2 and pheatmap R packages.</p>
</sec>
<sec id="S12">
<title>Single-cell RNAseq (scRNAseq) of severe COVID-19 patients</title>
<p id="P18">Single-cell transcriptomic data was analyzed from bronchoalveolar lavage fluid (BALF) from patients with varying severity of COVID-19 and matching healthy controls [<xref ref-type="bibr" rid="R31">31</xref>]. The dataset generated by the original authors is publicly available at <ext-link ext-link-type="uri" xlink:href="https://covid19-balf.cells.ucsc.edu/">https://covid19-balf.cells.ucsc.edu/</ext-link>. Briefly, the dataset was downloaded and the RDS seurat object was imported into R environment version v3.6.3. Epithelial cells were selected for downstream analysis based on the cell type annotation provided by the authors. Cells containing viral reads according to the original author’s annotation were labeled as “infected” and those in which no viral reads were detected were labeled as “bystanders”. Only cells from severe COVID-19 patients presented viral reads, therefore cells from moderate patients were discarded. Differential expression analysis was conducted using the FindMarkers function of the seurat package v3.1 [<xref ref-type="bibr" rid="R32">32</xref>] using Wilcoxon test to compare infected and bystander cells of severe patients to healthy control cells and also infected to bystander cells of severe patients. Differentially expressed genes were identified considering genes expressed in at least 10% of cells, FDR &lt; 0.05 and |avg_logFC| &gt; 0.25. Differentially expressed genes found in each individual comparison were submitted to GSEA using the fgsea R package with the same custom geneset file and selected terms used for the VeroE6 analysis described above. Violin plots of the expression of selected differentially expressed genes were produced using the VlnPlot function of the seurat package.</p>
</sec>
<sec id="S13">
<title>Western blotting</title>
<p id="P19">Proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes. Nitrocellulose membranes were blocked in a solution of TBS containing 5 % nonfat dry milk and 0.1 % Tween-20 for 2 h with constant agitation. After blocking, the membranes were incubated with anti-mTOR (Cell Signaling, #2972), anti p-mTOR (Cell Signaling, #2971), p-S6K1 (Cell Signaling, #9234), anti-S6K1 (Cell Signaling, #2708), anti-pS6 (Cell Signaling, #2215), anti-S6 (Cell Signaling, #2317), anti-pULK1 (Cell Signaling, #5869), anti-ATG7 (Cell Signaling, #8558), anti-LC3 (Cell Signaling, #4108), anti-p62 (Cell Signaling, #88588), and anti-β-actin (Cell Signaling, #4967), antibodies overnight at 4 °C. Membranes were washed with TBS-T (3 times for 10 min) and incubated with horseradish peroxidase-conjugated secondary antibodies anti-mouse (Millipore, #AP308P), or anti-rabbit (Thermo Scientific, #31460) according to the primary antibody for 1 h at room temperature with constant agitation. Bands were visualized using the ECL kit (GE Healthcare). Band densitometry was measured using ImageJ software.</p>
</sec>
<sec id="S14">
<title>Quantification and Statistical Analysis</title>
<p id="P20">The software packages GraphPad Prism 8.0 and 9.0 were used for statistical analyses of Western blotting and PFU, respectively. The values presented are means and standard deviation (SD). The mean difference was tested by Test T analysis. p&lt;0.05 were considered significant.</p>
</sec>
</sec>
<sec id="S15" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="S16">
<label>3.1</label>
<title>SARS-CoV-2 infection modulates mTOR signaling and autophagy in Vero E6 cells</title>
<p id="P21">We analyzed the mTOR and autophagy pathways in SARS-CoV-2 infected Vero E6 cells, measuring the levels of mTOR, S6K1 (Ribosomal protein S6 kinase beta-1), and S6 (Ribosomal protein S6) phosphorylation and LC3I/LC3II (Microtubule-associated protein light chain 3) and p62/SQSTM1 (Ubiquitin-binding protein p62/Sequestosome 1) protein content (<xref ref-type="fig" rid="F1">Figure 1</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S1</xref>). SARS-CoV-2 infected cells exhibited increased levels of mTOR, S6K1, and S6 phosphorylation by over 3-fold, compared to the baseline levels of mock cells (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The significantly increased mTOR and S6 phosphorylation levels can also be observed when we use the endogenous gene for their quantification (<xref ref-type="supplementary-material" rid="SD1">Figure S2</xref>). SQSTM1/p62 levels and LC3 conversion usually correlate with autophagic flux [<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R22">22</xref>].</p>
<p id="P22">Using confocal microscopy, immunofluorescence (IF) for p62 and the viral Spike protein revealed that SARS-CoV-2 colocalizes within autophagosomes in infected cells (<xref ref-type="fig" rid="F1">Figure 1B</xref>), but not with Lamp1 staining (<xref ref-type="fig" rid="F1">Figure 1C</xref>). RNAseq data from SARS-CoV-2-infected Vero E6 cells [<xref ref-type="bibr" rid="R23">23</xref>] revealed the downregulation of genes related to lysosomal activity and of the VAMP8 (Vesicle-associated membrane protein 8). VAMP8 is a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) involved in autophagosome-lysosome fusion [<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref>] (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
<p id="P23">These results demonstrate that SARS-CoV-2 infection in Vero E6 cells induces accumulation of autophagosome proteins in a cell environment with increased mTOR activity, a condition known to inversely correlate with lysosomal activity [<xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R36">36</xref>]. At the same time, the virus infection is associated with the repression of genes related to lysosome and vesicle fusion.</p>
</sec>
<sec id="S17">
<label>3.2</label>
<title>Severe COVID-19 patients display hyperactivation of mTOR signaling and suppression of autophagic flux and VAMP8</title>
<p id="P24">We then asked whether COVID-19 patients samples would also present some of the alterations observed in SARS-CoV-2 infected Vero E6 cells. We analyzed a publicly available single-cell RNAseq (scRNAseq) dataset of epithelial cells derived from bronchoalveolar lavage fluid (BALF) of severe COVID-19 patients [<xref ref-type="bibr" rid="R37">37</xref>] (<xref ref-type="fig" rid="F2">Figure 2A</xref>). scRNAseq allows the detection of the virus RNA in individual cells and the comparison of genome-wide gene expression changes between the infected cells and bystander (not infected) cells and cells of healthy controls. We found that both infected and bystander BALF epithelial cells of severe COVID-19 patients presented upregulation of mTOR signaling, repression of autophagy genes, and upregulation of negative regulators of autophagy, all compared to healthy controls (<xref ref-type="fig" rid="F2">Figure 2B-C</xref>). The same was shown for Vero E6 cells (<xref ref-type="fig" rid="F1">Figure 1A</xref> and <xref ref-type="fig" rid="F1">D</xref>), as already described. The expression of genes related to mTOR signaling was not altered in infected cells relative to bystanders (<xref ref-type="fig" rid="F2">Figure 2B</xref>). We suggest either a pre-existing condition of high mTOR signaling and compromised autophagy flux in severe COVID-19 patients or a cell effect elicited by the virus.</p>
<p id="P25">Differential gene expression analysis between infected and bystander BALF epithelial cells of severe COVID-19 patients recapitulated the downregulation of genes related to lysosome and vesicle membrane proteins (<xref ref-type="fig" rid="F2">Figure 2B-C</xref>) observed in Vero E6 cells. <italic>VAMP8</italic> was consistently downregulated in both infected and bystander BALF epithelial cells, with the lowest level of expression observed in infected cells from severe COVID-19 patients (<xref ref-type="fig" rid="F2">Figure 2D</xref>). <italic>SQSTM1</italic>, the gene encoding the p62 protein, on the other hand, was upregulated in bystander or infected cells from severe COVID-19 patients compared to healthy controls, with the highest expression detected in infected cells (<xref ref-type="fig" rid="F2">Figure 2D</xref>).</p>
</sec>
<sec id="S18">
<label>3.3</label>
<title>Vero E6 cells accumulate SARS-CoV-2 particles inside cells</title>
<p id="P26">In addition to the role of VAMP8 in autophagosome-lysosome fusion, this protein is also necessary for endosome and secretory vesicle fusion with the plasma membrane [<xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R40">40</xref>]. Since downregulation of VAMP8 and upregulation of mTOR genes involved in membrane fusion were demonstrated in both SARS-CoV-2 infected Vero E6 cells and BALF epithelial cells of severe COVID-19 patients, we next explored the possibility that SARS-CoV-2 infection could block exocytosis and reduce viral release. We compared the amount of viable SARS-CoV-2 particles (plaque-forming units - PFU) inside Vero E6 cells to the number of PFUs in the extracellular medium 24 hours post-infection (hpi) (<xref ref-type="fig" rid="F3">Figure 3</xref>). 20 times more SARS-CoV-2 particles were detected inside the cells than on the supernatant at 8 hpi, and 25 times more viral particles were retained inside the cells at 24 hpi (<xref ref-type="fig" rid="F3">Figure 3A</xref>).</p>
<p id="P27">These findings, combined with the repression of genes related to exocytosis in SARS-CoV-2 infection (<xref ref-type="fig" rid="F2">Figure 2C-D</xref>), suggest that the retention of viral particles inside infected cells could result from hampered exocytosis. To test this hypothesis, we treated SARS-CoV-2 infected Vero E6 cells with the exocytosis-inducer bafilomycin [<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R41">41</xref>]. Bafilomycin A1 is an inhibitor of vacuolarH+-ATPase (vATPase), an enzyme essential for lysosome acidification and degradation of autophagosome cargo [<xref ref-type="bibr" rid="R14">14</xref>]. The bafilomycin treatment did not significantly change the amount of SARS-CoV-2 particles inside the cells, but increased viral particles in the supernatant of bafilomycin-treated cells (<xref ref-type="fig" rid="F3">Figure 3B-C</xref>). These results suggest that exocytosis inhibition limits viral release to the extracellular medium in SARS-CoV-2 infected cell culture.</p>
</sec>
<sec id="S19">
<label>3.4</label>
<title>SARS-CoV-2 cell-to-cell transmission in CD63-positive vesicles</title>
<p id="P28">We then performed fluorescent in situ hybridization (FISH) and double IF to study the dynamics of newly formed SARS-CoV-2 particles inside the cells. In addition to the dot-like staining co-localized with p62, we identified vesicle-like labeling of the virus genetic material (<xref ref-type="fig" rid="F4">Figure 4A</xref>) and viral proteins (<xref ref-type="fig" rid="F4">Figure 4B</xref>), that co-localized entirely with CD63 (<xref ref-type="fig" rid="F4">Figure 4C-D</xref>), a marker for late endosome/multivesicular body (MVB). Strikingly, these virus-bearing CD63-positive vesicles were found in cell-to-cell connections at 24 hpi (<xref ref-type="fig" rid="F4">Figure 4D</xref>). These observations suggest that, upon assembly, viral particles loaded into CD63-positive vesicles accumulated inside infected cells, which may be transported to neighboring cells via cellular connections.</p>
</sec>
</sec>
<sec id="S20" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p id="P29">This study reports that SARS-CoV-2 infection induces transcriptional activation of autophagosome proteins and represses genes related to lysosomes and vesicle fusion in a scenario with high mTOR activity and repressed autophagy. We demonstrated these effects both in Vero E6 cells and in COVID-19 patients samples. By studying SARS-CoV-2 infection <italic>in vitro</italic>, using the Vero E6 cell line as a model, we further demonstrated that newly assembled viral particles are localized to autophagosomes and MVBs/late endosomes. Both organelles can be targeted to lysosomal degradation but, instead, they seem to accumulate in SARS-CoV-2 infected cells. We also observed SARS-CoV-2 viral particle retention in Vero E6 cells 24 hpi and demonstrated that CD63-positive vesicles loaded with viral particles are found in cell-to-cell connections (<xref ref-type="fig" rid="F4">Figure 4D</xref>).</p>
<p id="P30">The findings described in this report have major implications for our understanding of the SARS-CoV-2 infection and the causal factors for COVID-19 severity. First, although we found activation of the mTOR signaling in SARS-CoV-2 infected cells, our single-cell analysis of severe COVID-19 patients revealed that mTOR signaling is not altered between infected and bystander cells. However, this effect is detected by comparing bystander or infected cells to healthy controls. The same is observed for autophagy-related genes, reduced between COVID-19 patient cells and healthy controls, but not between infected and bystander patient cells. The results suggest that high mTOR signaling and compromised autophagy flux could be a cell response to the viral infection or pre-existing conditions that could contribute to the poor prognosis of the disease. In addition to blocking autophagy flux, high mTOR activity could favor cap-dependent translation of SARS-CoV-2 genomic and 3’-co-lateral capped subgenomic mRNAs [<xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R45">45</xref>].</p>
<p id="P31">mTOR signaling has been proposed as a factor linking obesity to COVID-19 severity [<xref ref-type="bibr" rid="R3">3</xref>] and was demonstrated to be modulated by SARS-CoV-2 infection in Huh7 [<xref ref-type="bibr" rid="R46">46</xref>] and Vero E6 [<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R47">47</xref>] cell lines (<xref ref-type="fig" rid="F1">Figure 1</xref>). In line with a possible causal role of high mTOR signaling favoring COVID-19 severity, mTOR inhibition resulted in a significant reduction in virus replication and may also inhibit viral particle uptake in Huh7, Vero E6 cells and mucociliary primary human airway derived air-liquid interface cultures [<xref ref-type="bibr" rid="R46">46</xref>,<xref ref-type="bibr" rid="R47">47</xref>]. Hyperactivation of mTOR signaling is present in hypertension [<xref ref-type="bibr" rid="R48">48</xref>], type-2 diabetes [<xref ref-type="bibr" rid="R49">49</xref>], including related to aging [<xref ref-type="bibr" rid="R50">50</xref>], ischemic heart disease [<xref ref-type="bibr" rid="R51">51</xref>], atrial fibrillation [<xref ref-type="bibr" rid="R52">52</xref>], chronic renal failure [<xref ref-type="bibr" rid="R53">53</xref>] dementia caused by Huntington’s [<xref ref-type="bibr" rid="R54">54</xref>] and Alzheimer’s [<xref ref-type="bibr" rid="R55">55</xref>] diseases, Chronic Obstructive Pulmonary Disease (COPD) [<xref ref-type="bibr" rid="R56">56</xref>], cancer [<xref ref-type="bibr" rid="R57">57</xref>], heart failure [<xref ref-type="bibr" rid="R58">58</xref>] and obesity [<xref ref-type="bibr" rid="R59">59</xref>]. These are ten comorbidities considered most prevalent in COVID-19 deceased patients (Palmieri et al., 2020). It is also known that elders are the most vulnerable group when affected by COVID-19, corresponding to 80% of hospitalized patients [<xref ref-type="bibr" rid="R1">1</xref>]. Increased mTOR signaling and reduced autophagy are hallmarks of aging [<xref ref-type="bibr" rid="R50">50</xref>]. Interventions that reduce mTOR signaling and promote autophagy prolong lifespan in different species and protect from diseases, including infectious diseases [<xref ref-type="bibr" rid="R60">60</xref>,<xref ref-type="bibr" rid="R61">61</xref>]. Indeed, the inhibition of mTOR pathway by mTORC1 inhibitors such as rapamycin and rapalogs reduced SARS-CoV-2 infection and N protein expression in Vero E6 and primary human airway-derived air-liquid interface cultures, endorsing our results [<xref ref-type="bibr" rid="R47">47</xref>].</p>
<p id="P32">Another important aspect of our findings is the dependence of SARS-CoV-2 on autophagosomes and the viral-induced blockage of the autophagic flux. We demonstrated here that SARS-CoV-2 colocalizes within autophagosomes in infected, but not with Lamp1. These results corroborate previous evidence that autophagosome-lysosome fusion is blocked during SARS-CoV-2 infection [<xref ref-type="bibr" rid="R62">62</xref>]. Several other groups have shown that coronaviruses can increase autophagosome accumulation and block their fusion with lysosomes through direct interactions between viral and cellular proteins [<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R62">62</xref>,<xref ref-type="bibr" rid="R63">63</xref>]. As demonstrated here for SARS-CoV-2, RNA viruses, such as the Hepatitis C Virus (HCV) and the Human Parainfluenza Virus Type 3 (HPIV3), hijack the autophagic machinery and lead to the accumulation of LC3II and p62 [<xref ref-type="bibr" rid="R64">64</xref>–<xref ref-type="bibr" rid="R67">67</xref>]. These strategies improve viral replication and improve the ability of these viruses to evade the host’s immune system [<xref ref-type="bibr" rid="R66">66</xref>,<xref ref-type="bibr" rid="R68">68</xref>–<xref ref-type="bibr" rid="R72">72</xref>]. For HPIV3, the impairment of the autophagic flux is caused by a virus-induced disruption of the function of the SNARE protein Synaptosome Associated Protein 29 (SNAP29), blocking its interaction with Syntaxin17 (STX17) and the formation of the SNAP-STX17-VAMP8 complex [<xref ref-type="bibr" rid="R65">65</xref>].</p>
<p id="P33">Although we did not find significant differences in the expression of the SNAP29 or STX17 genes between infected cells and controls in our analyses (data not shown), we demonstrate that VAMP8 is drastically repressed in infected Vero E6 cells and the BALF epithelial cells of severe COVID-19 patients. Recently, a study showed that overexpression of SARS-CoV-2 ORF3a protein in Vero E6 cells blocks the STX17-SNAP29-VAMP8 SNARE complex assembly, impairing the autophagic flux and late endosome integrity in infected cells. However, ORF3a overexpression alone did not significantly affect VAMP8 gene expression [<xref ref-type="bibr" rid="R62">62</xref>]. Therefore, the consistent repression of VAMP8 in Vero E6 cells and severe COVID-19 patients samples presented here cells also suggests that SARS-CoV-2 affects the SNARE complex also at the transcriptional level. Interestingly, increased mTOR activity is also essential for suppressing lysosomal biogenesis, autophagy, and lysosomal acidification [<xref ref-type="bibr" rid="R73">73</xref>], which might also be required to facilitate the fusion between autophagosomes and lysosomes [<xref ref-type="bibr" rid="R74">74</xref>,<xref ref-type="bibr" rid="R75">75</xref>]. These observations also support the role of increased mTOR signaling in COVID-19 severity.</p>
<p id="P34">A recent multi-omics study [<xref ref-type="bibr" rid="R76">76</xref>] revealed that SARS-CoV-2 infection induces phosphorylation of key proteins in the mTOR pathway, including SQSTM1. The study also shows that SARS-CoV-2 infection promotes ubiquitination of autophagy-related proteins, including VAMP8, suggesting protein degradation via the proteasome. The results of this multi-omics study are in agreement with our findings, showing that SARS-CoV-2 regulates mTOR activity and autophagy at different levels. Nonetheless, another study showed that SQSTM1/p62 levels did not change during SARS-CoV-2 infection [<xref ref-type="bibr" rid="R21">21</xref>]. We demonstrated that the ratio of the autophagosome markers LC3-II to LC3-I and the content of p62/SQSTM1 increase in infected cells (<xref ref-type="fig" rid="F1">Figure 1A</xref>), which is associate with the accumulation of autophagosomes by blockage of the autophagy flux [<xref ref-type="bibr" rid="R22">22</xref>].</p>
<p id="P35">SARS-CoV-2 infection in Vero E6 cells also resulted in the reduction of virus release from infected cells and transport of virus-loaded CD63-positive vesicles between neighboring cells (<xref ref-type="fig" rid="F3">Figures 3</xref> and <xref ref-type="fig" rid="F4">4</xref>). In contrast, SARS-CoV, which caused the 2003 SARS epidemics, presents ten times more viral particles in the supernatant than inside the cells at 12 hpi in Vero E6 cells [<xref ref-type="bibr" rid="R77">77</xref>]. MVBs fuse with the plasma membrane during exocytosis and release their intraluminal vesicles to the extracellular space as exosomes [<xref ref-type="bibr" rid="R78">78</xref>,<xref ref-type="bibr" rid="R79">79</xref>]. Although the exact mechanisms preventing SARS-CoV-2 release from cells need further clarification, we found that the expression of genes related to vesicle membrane and fusion, such as VAMP8 [<xref ref-type="bibr" rid="R33">33</xref>], are robustly repressed in Vero E6 infected cells and BALF epithelial cells of severe COVID-19 patient. Once again, elevated mTOR signaling found in COVID-19 patients might be sufficient to prevent exocytosis. The transcription factor EB (TFEB), which mTORC1 negatively regulates, is necessary for exocytosis of lysosomes [<xref ref-type="bibr" rid="R80">80</xref>] and autophagolysosomes [<xref ref-type="bibr" rid="R81">81</xref>]. This regulation occurs through the regulation of SNARE proteins syntaxins 4 and 6, which are necessary for the fusion of transport vesicles with the plasma membrane [<xref ref-type="bibr" rid="R82">82</xref>].</p>
<p id="P36">While higher resolution details and dynamics would help to dissect how vesicular traffic is affected by SARS-CoV-2 infection, we demonstrate here that virus-loaded CD63-positive vesicles accumulate inside the cells and are observed in membrane bridges between neighboring cells. SARS-CoV-2 viral particles have been observed in cellular protrusions in Caco-2 cells [<xref ref-type="bibr" rid="R83">83</xref>] and tunneling-nanotubes (TnT) between neighboring cells in Vero E6 cells. However, unlike what is shown here (<xref ref-type="fig" rid="F4">Figure 4</xref>), the viral particles were detected at the outer surface of these membrane bridges connecting Vero E6 cells [<xref ref-type="bibr" rid="R84">84</xref>]. The cell-to-cell transfer of viral components demonstrated here might represent an additional mechanism that SARS-CoV-2 uses to infect new cells while escaping the immune system and shed light on the virulence mechanisms and transmissibility SARS-CoV-2. For example, viral particle accumulation inside cells could explain cases of persistent systemic infection by SARS-CoV-2, the late onset of the symptoms, and the fact that many asymptomatic individuals are still able to produce infectious viral particles [<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R85">85</xref>,<xref ref-type="bibr" rid="R86">86</xref>].</p>
<p id="P37">This study was experimentally performed using Vero E6 cell culture, a largely accepted cell model for SARS-CoV-2 infection [<xref ref-type="bibr" rid="R87">87</xref>]. This model is limited since Vero E6 cells are derived from a non-human primate and are interferon-deficient [<xref ref-type="bibr" rid="R88">88</xref>]. Several in vitro studies performed in Vero E6 and human cell lines suggested promising effects of drugs on SARS-CoV-2 infection in cell lines [<xref ref-type="bibr" rid="R89">89</xref>–<xref ref-type="bibr" rid="R93">93</xref>] but few have been translated to the infection in patients. For this reason, we validated our hypothesis using a single-cell RNAseq dataset of severe COVID-19 patient lung epithelial cells. We detected similar gene expression results between the VeroE6 and patient experiments, supporting that SARS-CoV-2 blocks the autophagic flux and reduces vesicle membrane fusion, likely reducing viral release from the host cells and relating to a cell-to-cell viral transmission. However, it is still necessary to confirm that this phenomenon also occurs in human cells and tissues and is clinically relevant in COVID-19 patients.</p>
<p id="P38">Our findings may support the design new or the interpretation of current clinical trials of FDA-approved mTOR inhibitors. There are several active clinical trials registered on ClinicalTrials.gov for mTOR inhibitors, such as the rapamycin analog Sirolinus. These clinical trials are based on the proposed effects of rapamycin on restoring T-cell functionality and decrease cytokine storm [<xref ref-type="bibr" rid="R94">94</xref>,<xref ref-type="bibr" rid="R95">95</xref>], the direct antiviral effect [<xref ref-type="bibr" rid="R96">96</xref>], and in aging-related declining of the immune function [<xref ref-type="bibr" rid="R97">97</xref>]. Metformin, a medicine commonly used to treat Type 2 Diabetes and a well-known mTOR inhibitor [<xref ref-type="bibr" rid="R98">98</xref>], has been demonstrated to reduce COVID-19 mortality [<xref ref-type="bibr" rid="R99">99</xref>]. Among the possible mechanisms proposed to explain metformin’s positive effect on COVID-19 outcomes, the inhibition of the mTOR pathway could reduce the severity of COVID-19 disease by preventing immune hyperactivation [<xref ref-type="bibr" rid="R100">100</xref>,<xref ref-type="bibr" rid="R101">101</xref>].</p>
<p id="P39">Based on findings presented here we constructed the model presented in <xref ref-type="fig" rid="F5">Figure 5</xref>. conditions of low mTOR signaling, autophagy is promoted, and vesicles containing SARS-CoV-2 particles might fuse to acidified lysosomes and be eliminated or go directed to exocytosis, exposing the virus to the immune system (<xref ref-type="fig" rid="F5">Figure 5A</xref>). The SARS-CoV-2 infection seems to be favored by high mTOR activity, which could guarantee cap-dependent translation of viral proteins and lysosome deacidification, allowing viral assembly in autophagosomes and late endosomes (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Therefore, the machinery that promotes SARS-CoV-2 viral replication appears to prevent viral release, resulting in the accumulation of novel viral particles inside the cells, which may contribute to cell-to-cell transmission and evasion of the immune system.</p>
</sec>
<sec id="S21" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p id="P40">Here we show that mTOR activity and impairment of autophagy are important events of SARS-CoV-2 infection in vitro and in COVID-19 patients samples. Besides, markers of lysosome acidification like VAMP8 were demonstrated to be downregulated by SARS-CoV-2 infection, impacting the dynamics of viral particles released from cells. Finally, the subcellular localization of virus components presented here indicates complex mechanisms of cell-to-cell transmission, that are still to be further explored. In sum, we present evidence that the mTOR and autophagy pathways are important players in the dynamics of SARS-CoV-2 in the cell.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Figures</label>
<media xlink:href="EMS136958-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="N67106" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S22">
<title>Acknowledgments</title>
<p>The authors acknowledge the National Institute of Science and Technology of Photonics Applied to Cell Biology (INFABIC) and the technical support of Mariana Ozello Baratti, for aid with confocal microscopy and Elzira Saviani and Thais Theizen for technical support.</p>
<sec id="S23">
<title>Funding</title>
<p>This work was supported by grants from FAEPEX-UNICAMP (2005/20; 2319/20; 2432/20; 2274/20), São Paulo Research Foundation (FAPESP) (18/14933-2; 20/05284-0; 2014/50938-8; 2020/05346-6; 2020/04919-2; 2020/04558-0) and National Council for Scientific and Technological Development (CNPq) (465699/2014-6).</p>
</sec>
</ack>
<fn-group>
<fn id="FN1" fn-type="con">
<p id="P41">
<bold>Author Contributions:</bold> GCM, TLD, BB, MRA and EPZ led and performed experiments, literature search and data plotting and analyses. LNS; LB; JGAE; CM performed IF and HIS. MCSM, ICBP, APM, EPZ and LGSS performed WB. DATT, KBS, PLP, SPM, GFS and FG performed all SARS-CoV-2 infections in Vero E6 cell and PFU. IC performed bioinformatics. GOB performed confocal image processing. RGL, TLK and TDS performed cellular experiments. HC and LLPS contributed with reagents, insights and interpretation and discussions of the results. TLD, GCM, MRA and HMS generated all figures. GCM, MCSM, ICBP, FMS and HMS conceived the illustrative scheme. GCM and HMS formatted the manuscript. HMS, FMS, JLPM, HN and MAM supervised the study, interpreted the results and contributed to the discussion. HMS and FMS conceived and designed the study and wrote the manuscript. All the authors revised the manuscript and approved the final version for publication.</p>
</fn>
<fn id="FN2" fn-type="conflict">
<p id="P42">
<bold>Conflicts of Interest:</bold> The authors declare no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Espinosa</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Zanetti</surname>
<given-names>ADS</given-names>
</name>
<name>
<surname>Antunes</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Longhi</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>de Matos</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Battaglini</surname>
<given-names>PF</given-names>
</name>
</person-group>
<article-title>Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: A systematic review and meta-analysis</article-title>
<source>Rev Inst Med Trop Sao Paulo</source>
<year>2020</year>
<volume>62</volume>
<pub-id pub-id-type="doi">10.1590/S1678-9946202062043</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanyaolu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Okorie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marinkovic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Patidar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Younis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hosein</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Padda</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mangat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Altaf</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Comorbidity and its Impact on Patients with COVID-19</article-title>
<source>SN Compr Clin Med</source>
<year>2020</year>
<volume>2</volume>
<pub-id pub-id-type="doi">10.1007/s42399-020-00363-4</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolourian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mojtahedi</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Obesity and COVID-19: The mTOR pathway as a possible culprit</article-title>
<source>Obes Rev</source>
<year>2020</year>
<volume>21</volume>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Kurth</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wollner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nasci</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zheleznova</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Bukowy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dayton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cowley</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Therapeutic suppression of mTOR (Mammalian Target of Rapamycin) signaling prevents and reverses salt-induced hypertension and kidney injury in dahl salt-sensitive rats</article-title>
<source>Hypertension</source>
<year>2019</year>
<volume>73</volume>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.118.12378</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mühlebner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bongaarts</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sarnat</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Scholl</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives</article-title>
<source>J Anat</source>
<year>2019</year>
<volume>235</volume>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chapuis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Saint Marcoux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Recher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Prebet</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chevallier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cahn</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Leguay</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bories</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Witz</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse</article-title>
<source>Leukemia</source>
<year>2013</year>
<volume>27</volume>
<pub-id pub-id-type="doi">10.1038/leu.2013.17</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sciarretta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Forte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frati</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sadoshima</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>New insights into the role of mtor signaling in the cardiovascular system</article-title>
<source>Circ Res</source>
<year>2018</year>
<volume>122</volume>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergès</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cariou</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>MTOR inhibitors and diabetes</article-title>
<source>Diabetes Res Clin Pract</source>
<year>2015</year>
<volume>110</volume>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavares</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Pavan</surname>
<given-names>ICB</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Meneguello</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Luchessi</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Simabuco</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>The S6K protein family in health and disease</article-title>
<source>Life Sci</source>
<year>2015</year>
<volume>131</volume>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxton</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>mTOR Signaling in Growth, Metabolism, and Disease</article-title>
<source>Cell</source>
<year>2017</year>
<volume>168</volume>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boya</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Reggiori</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Codogno</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Emerging regulation and functions of autophagy</article-title>
<source>Nat Cell Biol</source>
<year>2013</year>
<volume>15</volume>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dossou</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The emerging roles of mTORC1 in macromanaging autophagy</article-title>
<source>Cancers (Basel)</source>
<year>2019</year>
<volume>11</volume>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Bouhaddou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Obernier</surname>
<given-names>K</given-names>
</name>
<name>
<surname>White</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>O’Meara</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Rezelj</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Swaney</surname>
<given-names>DL</given-names>
</name>
<etal/>
</person-group>
<article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title>
<source>Nature</source>
<year>2020</year>
<volume>583</volume>
<fpage>459</fpage>
<lpage>468</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-020-2286-9</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gassen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Papies</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bajaj</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dethloff</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Emanuel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weckmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Heinz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lennarz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics</article-title>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.15.997254</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>ORF3a mediated-incomplete autophagy facilitates SARS-CoV-2 replication</article-title>
<comment>Qu, Y., Wang, X., Zhu, Y., Wang, Y., Yang, X., Hu, G., … Liang, Q. (n.d.). ORF3a mediated-incomplete autophagy facilitates SARS-CoV-2 replication. https://doi.org/10.1101/2020.11.12.380</comment>
<pub-id pub-id-type="doi">10.1101/2020.11.12.380709</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benefield</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Skrip</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Clement</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Althouse</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Althouse</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies</article-title>
<source>medRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauer</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Grantz</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>FK</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Meredith</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Azman</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Reich</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Lessler</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and application</article-title>
<source>Ann Intern Med</source>
<year>2020</year>
<volume>172</volume>
<pub-id pub-id-type="doi">10.7326/M20-0504</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cruz-cosme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins</article-title>
<source>Signal Transduct Target Ther</source>
<year>2020</year>
<volume>5</volume>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araujo</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>RRG</given-names>
</name>
<name>
<surname>Amgarten</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>de M Malta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>de Araujo</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>CO</given-names>
</name>
<name>
<surname>Candido</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>de Menezes</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>ACC</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 isolation from the first reported patients in brazil and establishment of a coordinated task network</article-title>
<source>Mem Inst Oswaldo Cruz</source>
<year>2020</year>
<volume>115</volume>
<pub-id pub-id-type="doi">10.1590/0074-02760200342</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rocco</surname>
<given-names>PRM</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>MAC</given-names>
</name>
<name>
<surname>Tierno</surname>
<given-names>PFGMM</given-names>
</name>
<name>
<surname>Moura</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>LFG</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Dos Santos</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Junior</surname>
<given-names>WF</given-names>
</name>
<etal/>
</person-group>
<article-title>Early use of nitazoxanide in mild COVID-19 disease: Randomised, placebo-controlled trial</article-title>
<source>Eur Respir J</source>
<year>2021</year>
<volume>58</volume>
<pub-id pub-id-type="doi">10.1183/13993003.03725-2020</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>MZX</given-names>
</name>
<etal/>
</person-group>
<article-title>ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication</article-title>
<source>Front Cell Dev Biol</source>
<year>2021</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.3389/fcell.2021.716208</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gassen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Papies</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bajaj</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Emanuel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dethloff</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Trimpert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Niemeyer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Weege</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals</article-title>
<source>Nat Commun</source>
<year>2021</year>
<volume>12</volume>
<pub-id pub-id-type="doi">10.1038/s41467-021-24007-w</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riva</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Martin-Sancho</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Matsunaga</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pache</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Burgstaller-Muehlbacher</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De Jesus</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Teriete</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>MV</given-names>
</name>
<etal/>
</person-group>
<article-title>Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing</article-title>
<source>Nature</source>
<year>2020</year>
<volume>586</volume>
<pub-id pub-id-type="doi">10.1038/s41586-020-2577-1</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deprez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zaragosi</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Truchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Becavin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>García</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Arguel</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Plaisant</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Magnone</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lebrigand</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Abelanet</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>A single-cell atlas of the human healthy airways</article-title>
<source>Am J Respir Crit Care Med</source>
<year>2020</year>
<volume>202</volume>
<pub-id pub-id-type="doi">10.1164/rccm.201911-2199OC</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Duggal</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Irizarry</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Kingsford</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title>
<source>Nat Methods</source>
<year>2017</year>
<volume>14</volume>
<pub-id pub-id-type="doi">10.1038/nmeth.4197</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soneson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title>
<source>F1000Research</source>
<year>2015</year>
<volume>4</volume>
<pub-id pub-id-type="doi">10.12688/f1000research.7563.1</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
<source>Genome Biol</source>
<year>2014</year>
<volume>15</volume>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korotkevich</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sukhov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Budin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shpak</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Artyomov</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sergushichev</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fast gene set enrichment analysis</article-title>
<year>2016</year>
<pub-id pub-id-type="doi">10.1101/060012</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mootha</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Paulovich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pomeroy</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Golub</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>ES</given-names>
</name>
<etal/>
</person-group>
<article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genomewide expression profiles</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2005</year>
<volume>102</volume>
<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mootha</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Lindgren</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sihag</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lehar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Puigserver</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ridderstråle</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Laurila</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>PGC-lα-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title>
<source>Nat Genet</source>
<year>2003</year>
<volume>34</volume>
<pub-id pub-id-type="doi">10.1038/ng1180</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19</article-title>
<source>Nat Med</source>
<year>2020</year>
<volume>26</volume>
<pub-id pub-id-type="doi">10.1038/s41591-020-0901-9</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Andersen-Nissen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mauck</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Wilk</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Darby</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zager</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Integrated analysis of multimodal single-cell data</article-title>
<source>Cell</source>
<year>2021</year>
<volume>184</volume>
<pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furuta</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Amano</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>SNARE mediates autophagosome-lysosome fusion</article-title>
<source>J Oral Biosci</source>
<year>2012</year>
<volume>54</volume>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>New insights regarding SNARE proteins in autophagosome-lysosome fusion</article-title>
<source>Autophagy</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>MTOR: A pharmacologic target for autophagy regulation</article-title>
<source>J Clin Invest</source>
<year>2015</year>
<volume>125</volume>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leprivier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rotblat</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>How does mTOR sense glucose starvation? AMPK is the usual suspect</article-title>
<source>Cell Death Discov</source>
<year>2020</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.1038/s41420-020-0260-9</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing</article-title>
<source>Nat Med</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.02.23.20026690</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Holroyd</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tikkanen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Honing</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jahn</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The R-SNARE endobrevin/VAMP-8 mediates homotypic fusion of early endosomes and late endosomes</article-title>
<source>Mol Biol Cell</source>
<year>2000</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.1091/mbc.11.10.3289</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malmersjö</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Di Palma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Diao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pfuetzner</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hayer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Porteus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bodenmiller</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Phosphorylation of residues inside the SNARE complex suppresses secretory vesicle fusion</article-title>
<source>EMBO J</source>
<year>2016</year>
<volume>35</volume>
<pub-id pub-id-type="doi">10.15252/embj.201694071</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Pattu</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Halimani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maier-Peuschel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Becherer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hoth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tschernig</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bryceson</surname>
<given-names>YT</given-names>
</name>
<etal/>
</person-group>
<article-title>VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity</article-title>
<source>J Cell Biol</source>
<year>2015</year>
<volume>210</volume>
<pub-id pub-id-type="doi">10.1083/jcb.201411093</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camacho</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Borges</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Intravesicular calcium release mediates the motion and exocytosis of secretory organelles: A study with adrenal chromaffin cells</article-title>
<source>J Biol Chem</source>
<year>2008</year>
<volume>283</volume>
<pub-id pub-id-type="doi">10.1074/jbc.M800552200</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of coronavirus RNA capping and methylation</article-title>
<source>Virol Sin</source>
<year>2016</year>
<volume>31</volume>
<pub-id pub-id-type="doi">10.1007/s12250-016-3726-4</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nandagopal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Roux</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Regulation of global and specific mRNA translation by the mTOR signaling pathway</article-title>
<source>Translation</source>
<year>2015</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.4161/21690731.2014.983402</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roux</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Topisirovic</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Signaling Pathways Involved in the Regulation of mRNA Translation</article-title>
<source>Mol Cell Biol</source>
<year>2018</year>
<volume>38</volume>
<pub-id pub-id-type="doi">10.1128/mcb.00070-18</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simabuco</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Pavan</surname>
<given-names>ICB</given-names>
</name>
<name>
<surname>Morale</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses</article-title>
<source>Genet Mol Biol</source>
<year>2021</year>
<volume>44</volume>
<pub-id pub-id-type="doi">10.1590/1678-4685-gmb-2020-0212</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Appelberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Akusjärvi</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Ambikan</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Mikaeloff</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Saccon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Végvári</surname>
<given-names>Á</given-names>
</name>
<name>
<surname>Benfeitas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sperk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ståhlberg</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells</article-title>
<source>Emerg Microbes Infect</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1080/22221751.2020.1799723</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullen</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Purkayastha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matulionis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Momcilovic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Langerman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ramaiah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shackelford</surname>
<given-names>DB</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition</article-title>
<source>Nat Commun</source>
<year>2021</year>
<volume>12</volume>
<pub-id pub-id-type="doi">10.1038/s41467-021-22166-4</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pena</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kobir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goncharov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kudryashova</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vanderpool</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baust</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mora</surname>
<given-names>AL</given-names>
</name>
<etal/>
</person-group>
<article-title>Pharmacological inhibition of mtor kinase reverses right ventricle remodeling and improves right ventricle structure and function in rats</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>2017</year>
<volume>57</volume>
<pub-id pub-id-type="doi">10.1165/rcmb.2016-0364OC</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Efeyan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zoncu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Amino acids and mTORC1: From lysosomes to disease</article-title>
<source>Trends Mol Med</source>
<year>2012</year>
<volume>18</volume>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guillén</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benito</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>MTORC1 overactivation as a key aging factor in the progression to type 2 diabetes mellitus</article-title>
<source>Front Endocrinol (Lausanne)</source>
<year>2018</year>
<volume>9</volume>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sciarretta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Volpe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sadoshima</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Mammalian target of rapamycin signaling in cardiac physiology and disease</article-title>
<source>Circ Res</source>
<year>2014</year>
<volume>114</volume>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tse</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Rapamycin attenuates atrial fibrosis in 5/6 nephrectomized rats by inhibiting mammalian target of rapamycin and profibrotic signaling</article-title>
<source>Int J Hear Rhythm</source>
<year>2017</year>
<volume>2</volume>
<pub-id pub-id-type="doi">10.4103/ijhr.ijhr_1_17</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pérez</surname>
<given-names>JCR</given-names>
</name>
</person-group>
<article-title>El papel de los inhibidores de mTOR en las enfermedades renales</article-title>
<source>Nefrologia</source>
<year>2011</year>
<volume>31</volume>
<pub-id pub-id-type="doi">10.3265/Nefrologia.pre2011.Apr.10947</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Tecedor</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Monteys</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Sowada</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Reinstating aberrant mTORC1 activity in huntington’s disease mice improves disease phenotypes</article-title>
<source>Neuron</source>
<year>2015</year>
<volume>85</volume>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.019</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>ZC</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Targeting the mTOR signaling network for alzheimer’s disease therapy</article-title>
<source>Mol Neurobiol</source>
<year>2014</year>
<volume>49</volume>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houssaini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Breau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kebe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Abid</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marcos</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lipskaia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rideau</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parpaleix</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Amsellem</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>
<article-title>mTOR pathway activation drives lung cell senescence and emphysema</article-title>
<source>JCI insight</source>
<year>2018</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.1172/jci.insight.93203</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skeen</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Bhaskar</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>ding Peng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Nogueira</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hahn-Windgassen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kiyokawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner</article-title>
<source>Cancer Cell</source>
<year>2006</year>
<volume>10</volume>
<pub-id pub-id-type="doi">10.1016/j.ccr.2006.08.022</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling</article-title>
<source>Int J Mol Med</source>
<year>2020</year>
<volume>45</volume>
<pub-id pub-id-type="doi">10.3892/ijmm.2019.4407</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>LQ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects</article-title>
<source>Trends Pharmacol Sci</source>
<year>2016</year>
<volume>37</volume>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mannick</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hockey</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>Roma</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Beibel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kulmatycki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shavlakadze</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>TORC1 inhibition enhances immune function and reduces infections in the elderly</article-title>
<source>Sci Transl Med</source>
<year>2018</year>
<volume>10</volume>
<pub-id pub-id-type="doi">10.1126/scitranslmed.aaq1564</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walters</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>LS</given-names>
</name>
</person-group>
<article-title>mTORC inhibitors as broad-spectrum therapeutics for age-related diseases</article-title>
<source>Int J Mol Sci</source>
<year>2018</year>
<volume>19</volume>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation</article-title>
<source>Dev Cell</source>
<year>2021</year>
<volume>56</volume>
<pub-id pub-id-type="doi">10.1016/j.devcel.2020.12.010</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity</article-title>
<source>Protein Cell</source>
<year>2014</year>
<volume>5</volume>
<pub-id pub-id-type="doi">10.1007/s13238-014-0104-6</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bird</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Maynard</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Covert</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Kirkegaard</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Nonlytic viral spread enhanced by autophagy components</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2014</year>
<volume>111</volume>
<pub-id pub-id-type="doi">10.1073/pnas.1401437111</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Phosphoprotein of human parainfluenza virus type 3 blocks autophagosome-lysosome fusion to increase virus production</article-title>
<source>Cell Host Microbe</source>
<year>2014</year>
<volume>15</volume>
<pub-id pub-id-type="doi">10.1016/j.chom.2014.04.004</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bowman</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>JU</given-names>
</name>
</person-group>
<article-title>Autophagy during viral infection - A double-edged sword</article-title>
<source>Nat Rev Microbiol</source>
<year>2018</year>
<volume>16</volume>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SSL</given-names>
</name>
</person-group>
<article-title>Autophagy in hepatitis C virus-host interactions: Potential roles and therapeutic targets for liver-associated diseases</article-title>
<source>World J Gastroenterol</source>
<year>2014</year>
<volume>20</volume>
<pub-id pub-id-type="doi">10.3748/wjg.v20.i19.5773</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenuto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Angeletti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Giovanetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pascarella</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cauda</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ciccozzi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cassone</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy</article-title>
<source>J Infect</source>
<year>2020</year>
<volume>81</volume>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.058</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>St Croix</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Good</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Myerburg</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Pilewski</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Cellular Autophagy</article-title>
<source>iScience</source>
<year>2020</year>
<volume>23</volume>
<pub-id pub-id-type="doi">10.1016/j.isci.2020.101256</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miyagawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kusanaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ogino</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Minami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hino</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Correlation of hepatitis C virus-mediated endoplasmic reticulum stress with autophagic flux impairment and hepatocarcinogenesis</article-title>
<source>Med Mol Morphol</source>
<year>2021</year>
<volume>54</volume>
<pub-id pub-id-type="doi">10.1007/s00795-020-00271-5</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sir</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wakita</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>TSB</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>JHJ</given-names>
</name>
</person-group>
<article-title>Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response</article-title>
<source>Hepatology</source>
<year>2008</year>
<volume>48</volume>
<pub-id pub-id-type="doi">10.1002/hep.22464</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ploen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hildt</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy</article-title>
<source>World J Gastroenterol</source>
<year>2015</year>
<volume>21</volume>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puertollano</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>mTOR and lysosome regulation</article-title>
<source>F1000Prime Rep</source>
<year>2014</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.12703/P6-52</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Settembre</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zoncu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Vetrini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Erdin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Erdin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ferron</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vellard</surname>
<given-names>MC</given-names>
</name>
<etal/>
</person-group>
<article-title>A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB</article-title>
<source>EMBO J</source>
<year>2012</year>
<volume>31</volume>
<pub-id pub-id-type="doi">10.1038/emboj.2012.32</pub-id>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Settembre</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Di Malta</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Polito</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Arencibia</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Vetrini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Erdin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Erdin</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Colella</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>TFEB links autophagy to lysosomal biogenesis</article-title>
<source>Science (80-)</source>
<year>2011</year>
<volume>332</volume>
<pub-id pub-id-type="doi">10.1126/science.1204592</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stukalov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Girault</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Grass</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Karayel</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bergant</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Oubraham</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV</article-title>
<source>Nature</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1038/s41586-021-03493-4</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keyaerts</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vijgen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Neyts</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Van Ranst</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Growth kinetics of SARS-coronavirus in Vero E6 cells</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2005</year>
<volume>329</volume>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2005.02.085</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Niel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Charrin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Simoes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Romao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rochin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Saftig</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Rubinstein</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Raposo</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The Tetraspanin CD63 Regulates ESCRT-Independent and -Dependent Endosomal Sorting during Melanogenesis</article-title>
<source>Dev Cell</source>
<year>2011</year>
<volume>21</volume>
<pub-id pub-id-type="doi">10.1016/j.devcel.2011.08.019</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Physiological and pathological roles of exosomes in the nervous system</article-title>
<source>Biomol Concepts</source>
<year>2016</year>
<volume>7</volume>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medina</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Fraldi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bouche</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Annunziata</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mansueto</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Spampanato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Puri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pignata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martina</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sardiello</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Transcriptional activation of lysosomal exocytosis promotes cellular clearance</article-title>
<source>Dev Cell</source>
<year>2011</year>
<volume>21</volume>
<pub-id pub-id-type="doi">10.1016/j.devcel.2011.07.016</pub-id>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spampanato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feeney</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cardone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Annunziata</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zare</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Polishchuk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Puertollano</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Parenti</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease</article-title>
<source>EMBO Mol Med</source>
<year>2013</year>
<volume>5</volume>
<pub-id pub-id-type="doi">10.1002/emmm.201202176</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmieri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Impey</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>di Ronza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pelz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sardiello</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ballabio</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways</article-title>
<source>Hum Mol Genet</source>
<year>2011</year>
<volume>20</volume>
<pub-id pub-id-type="doi">10.1093/hmg/ddr306</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouhaddou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Memon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>White</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Rezelj</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Correa Marrero</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Polacco</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Melnyk</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Ulferts</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaake</surname>
<given-names>RM</given-names>
</name>
<etal/>
</person-group>
<article-title>The Global Phosphorylation Landscape of SARS-CoV-2 Infection</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.06.034</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caldas</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Carneiro</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Higa</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>da Costa</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Durigon</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Tanuri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution scanning electron microscopy</article-title>
<source>Sci Rep</source>
<year>2020</year>
<volume>10</volume>
<pub-id pub-id-type="doi">10.1038/s41598-020-73162-5</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Choudhary</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sparks</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Padera</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>H-H</given-names>
</name>
<name>
<surname>Boucau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bowman</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host</article-title>
<source>N Engl J Med</source>
<year>2020</year>
<volume>383</volume>
<pub-id pub-id-type="doi">10.1056/nejmc2031364</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voloch</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>de Almeida</surname>
<given-names>LGP</given-names>
</name>
<name>
<surname>Brustolini</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>de C Guimarães</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>de Carvalho Leitão</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mariani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>VA</given-names>
</name>
<etal/>
</person-group>
<article-title>Intra-host evolution during SARS-CoV-2 persistent infection</article-title>
<source>medRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogando</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Dalebout</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Zevenhoven-Dobbe</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Limpens</surname>
<given-names>RWAL</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Caly</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Druce</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>JJC</given-names>
</name>
<name>
<surname>Kikkert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barcena</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-coronavirus-2 replication in Vero E6 cells: Replication kinetics, rapid adaptation and cytopathology</article-title>
<source>J Gen Virol</source>
<year>2020</year>
<volume>101</volume>
<pub-id pub-id-type="doi">10.1099/jgv.0.001453</pub-id>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prescott</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Acuna-Retamar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wathelet</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Ebihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Feldmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hjelle</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>New world hantaviruses activate IFNλ production in type I IFN-deficient vero E6 cells</article-title>
<source>PLoS One</source>
<year>2010</year>
<volume>5</volume>
<pub-id pub-id-type="doi">10.1371/journal.pone.0011159</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Genomics functional analysis and drug screening of SARS-CoV-2</article-title>
<source>Genes Dis</source>
<year>2020</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.1016/j.gendis.2020.04.002</pub-id>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Anti-COVID-19 drug screening: Frontier concepts and core technologies</article-title>
<source>Chinese Med (United Kingdom)</source>
<year>2020</year>
<volume>15</volume>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schloer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brunotte</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mecate-Zambrano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ludwig</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rescher</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro</article-title>
<source>Br J Pharmacol</source>
<year>2021</year>
<volume>178</volume>
<pub-id pub-id-type="doi">10.1111/bph.15418</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Senger</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Evangelista</surname>
<given-names>TCS</given-names>
</name>
<name>
<surname>Dantas</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>da S Santana</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Gonçalves</surname>
<given-names>LCS</given-names>
</name>
<name>
<surname>de S Neto</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Silva-Junior</surname>
<given-names>FP</given-names>
</name>
</person-group>
<article-title>COVID-19: Molecular targets, drug repurposing and new avenues for drug discovery</article-title>
<source>Mem Inst Oswaldo Cruz</source>
<year>2020</year>
<volume>115</volume>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Touret</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gilles</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barral</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nougairède</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Helden</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Decroly</surname>
<given-names>E</given-names>
</name>
<name>
<surname>de Lamballerie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Coutard</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication</article-title>
<source>Sci Rep</source>
<year>2020</year>
<volume>10</volume>
<pub-id pub-id-type="doi">10.1038/s41598-020-70143-6</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omarjee</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Janin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Perrot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Laviolle</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Meilhac</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Mahe</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19</article-title>
<source>Clin Immunol</source>
<year>2020</year>
<volume>216</volume>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines</article-title>
<source>J Med Virol</source>
<year>2020</year>
<volume>92</volume>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</article-title>
<source>Cell Discov</source>
<year>2020</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.1038/s41421-020-0153-3</pub-id>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bischof</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Siow</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Zhavoronkov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaeberlein</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19</article-title>
<source>Lancet Heal Longev</source>
<year>2021</year>
<volume>2</volume>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>O’Callaghan</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth</article-title>
<source>Br J Clin Pharmacol</source>
<year>2019</year>
<volume>85</volume>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheen</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Metformin and COVID-19: From cellular mechanisms to reduced mortality</article-title>
<source>Diabetes Metab</source>
<year>2020</year>
<volume>46</volume>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehrer</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)</article-title>
<source>World Acad Sci J</source>
<year>2020</year>
<volume>2</volume>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sadasivam</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Metformin in COVID-19: A possible role beyond diabetes</article-title>
<source>Diabetes Res Clin Pract</source>
<year>2020</year>
<volume>164</volume>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>SARS-CoV-2 infection activates the mTOR pathway and impairs autophagy in Vero E6 cells.</title>
<p>
<bold>(A)</bold> mTOR, p-mTOR, S6K1, p-S6K1, S6, p-S6, LC3I/II, p62, and N immunoblotting of Vero E6 cells protein extracts 24 hpi. β-actin and Vinculin were used as endogenous control. Raw images are available in <xref ref-type="supplementary-material" rid="SD1">Figure S2</xref>. <bold>(B)</bold> IF demonstrating co-localization (yellow dots) of autophagosome protein p62 and SARS-CoV-2 Spike protein in Vero E6 cells M.O.I.=1. <bold>(C)</bold> IF for lysosomal protein Lamp1 (red) and SARS-CoV-2 Spike protein (green) showing no co-localization (yellow) in Vero E6 cells MOI=1. <bold>(D)</bold> Downregulation of genes related to lysosomal activity and of VAMP8, a SNARE responsible for autophagosome-lysosome fusion, in Vero E6 cells. All experiments were infected with MOI =1 Data represent means ± SD in samples from independent experiments in each experiment. T-test was used for immunoblotting analysis. *p&lt;0.05 were considered statistically significant.</p>
</caption>
<graphic xlink:href="EMS136958-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>scRNAseq analysis in COVID-19 patients.</title>
<p>
<bold>(A)</bold> Bronchoalveolar lavage fluid (BALF) samples of severe COVID-19 patients and matched controls were submitted to scRNAseq [<xref ref-type="bibr" rid="R37">37</xref>]. Epithelial cells were isolated from the other cell types and those in which viral reads were detected were labeled as infected. The remaining cells of COVID-19 patients were labeled as bystanders. <bold>(B)</bold> Gene Set enrichment analysis (GSEA) of differentially expressed genes in severe COVID-19 patient bystander or infected BALF epithelial cells versus control cells or infected versus bystander cells of severe patients. <bold>(C)</bold> Fold change values (log2FC) of the leading-edge genes of enriched Reactome terms depicted in B for SARS-CoV-2 infected VeroE6 cells and scRNAseq of severe COVID-19 patients BALF epithelial cells. <bold>(D)</bold> Expression level of SQSTM1 and VAMP8 in control (red), bystander (green) and infected (blue) BALF epithelial cells. *** differential expression adjusted p-value &lt; 0.01.</p>
</caption>
<graphic xlink:href="EMS136958-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>PFU and Bafilomycin treatment 24 hpi in Vero E6 cells.</title>
<p>
<bold>(A)</bold> Plaque-Forming units assay of cell lysate and supernatant of Vero E6 cell culture 8 and 24 hpi with SARS-CoV-2. <bold>(B)</bold> Plaque-Forming units assay of cell lysate and <bold>(C)</bold> supernatant of Vero E6 cell culture treated with 10 nM bafilomycin after 24 hpi with SARS-CoV-2. Bars represent mean ± SEM. Statistic difference is indicated by *p&lt;0.05.</p>
</caption>
<graphic xlink:href="EMS136958-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>SARS-CoV-2 detection in cell-to-cell connections in Vero E6 cells by fluorescent in situ hybridization</title>
<p>
<bold>(A)</bold> and immunofluorescence <bold>(B, C, D)</bold>. FISH for the RNA-dependent RNA polymerase gene showing vesicle-like labeling in a connection between two neighboring cells <bold>(A)</bold>. IF for Spike protein <bold>(B)</bold> double-stained with CD63 <bold>(C)</bold>, demonstrating viral-containing late endosomes/MVBs in cell-to-cell connections <bold>(D)</bold>.</p>
</caption>
<graphic xlink:href="EMS136958-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Proposed molecular mechanisms of SARS-CoV-2 infection upon high mTOR activation and compromised autophagy flux and vesicle fusion.</title>
<p>
<bold>(A)</bold> Classical autophagy flux, in low mTOR conditions, where SNARE proteins allow for vesicle fusion to acidified lysosome and vesicles fusion to the cell membrane. <bold>(B)</bold> High mTOR scenario depicting a SARS-CoV-2 viral infection. Newly assembled viral particles, associated with cellular vesicles (1), are prevented from being destroyed by lysosomal fusion as the expression of genes coding for vesicle fusion proteins (2) and lysosomal genes (3) are down-regulated, lysosomes are deacidified (31), and lysosomal fusion to virus-bearing vesicles, prevented (31, 32). The suppression of vesicle-membrane fusion proteins, such as VAMP8 (4), would prevent virus release from infected cells. Virus-bearing MVBs accumulate in infected cells (5) and are observed in cell-to-cell connections (6). Labeling 1-6 represents the original evidence of this manuscript. Created with <ext-link ext-link-type="uri" xlink:href="http://BioRender.com">BioRender.com</ext-link>
</p>
</caption>
<graphic xlink:href="EMS136958-f005"/>
</fig>
</floats-group>
</article>
